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Abstract
Objective We aimed to describe a pattern of rim uptake
observed in lung infarction on FDG-PET/CT, called the
“rim sign.” It was defined as a continuous slight FDG
uptake along the border of a subpleural consolidation with-
out uptake within the consolidation.
Methods We retrospectively reviewed the FDG-PET/CT
studies of 400 patients referred for thoracic oncological
workup from November 2010 to July 2011. The rim sign
was observed in six patients who had confirmed pulmonary
infarction (PI) on MDCT showing acute pulmonary embo-
lism (n04) or tumoral arterial obstruction (n02).
Results Eight PIs in the six patients exhibited the rim sign
with slight uptake (median SUVmax: 3.6, 2.2–6.8) and
median size of 48.5 mm (30–74). On MDCT, central lucen-
cies, triangular shape and vessel sign were observed in 5/8,
4/8 and 1/8 cases, respectively. Two out of the eight PIs
exhibited only the rim sign and none the suggestive MDCT
sign.
Conclusion The rim sign is easily recognisable at FDG-
PET/CT and is strongly suggestive of PI. This pattern can
be observed even in the absence of suggestive findings on
MDCT. Recognition of this sign should prompt investiga-
tions for pulmonary embolism.
Main Messages
• The rim sign is a slight FDG uptake around an area
of subpleural consolidation
• The rim sign is strongly suggestive of pulmonary infarction
• Recognition of the rim sign should prompt investigations
for pulmonary embolism
Keywords Pulmonary infarction . Pulmonary embolism .
FDG-PET/CT . Pattern
Introduction
Incidental pulmonary embolism is a not an uncommon
diagnosis in patients with cancer. There is a wide body of
evidence showing the higher incidence of deep venous
thrombosis and pulmonary embolism in this population,
for both in- and outpatients, supporting the existence of a
link between cancer and activation of the hemostatic system
[1, 2]. Anticancer therapy is also recognised to increase the
risk of deep venous thrombosis and pulmonary embolism
[2]. Positron emission tomography/computed tomography
with fluorodeoxyglucose (FDG-PET/CT) being now a stan-
dard procedure in the management of several malignancies,
most cancer patients undergoing FDG-PET/CT are at risk for
pulmonary embolism. Pulmonary embolism is associatedwith
pulmonary infarction in about 25 % of cases, often appearing
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as a non-specific peripheral wedge-shaped parenchymal con-
solidation [3, 4]. As most of FDG-PET/CT protocols do not
include contrast-enhanced CT, pulmonary infarction might
appear as a unique consolidation with variable FDG uptake
that can mimic a primary tumor or lead to an overestimation of
the tumor burden in patients with various malignancies [5].
That the quantitative parameters offered by PET technology
are hampered inmaking the distinction between infarction and
tumoral uptake because of the inflammatory processes asso-
ciated with pulmonary infarction is noteworthy. Thus,
occult lung infarction may induce false interpretation of
FDG-PET/CT in the staging of pulmonary malignancies
because of the wide overlap between the maximum
standardised uptake values (SUVmax) measured in pul-
monary infarction and in tumoral lesions [5].
We present the FDG-PET/CT investigations of six
patients with confirmed pulmonary infarction and suggest
a distinguishable metabolic pattern, the rim sign, which may
help the nuclear medicine physician make this difficult
diagnosis in daily practice.
Materials and methods
This study was institutional review board approved, with
waiver of informed consent. We retrospectively reviewed
consecutive FDG-PET/CT studies of 400 patients referred
for thoracic oncological workup from November 2010 to
July 2011. The rim sign was observed in six patients (5 men
and 1 woman; age 53–89, median 56) who were included in
this case series study. The rim sign was defined on FDG-
PET/CT as the association of (1) a continuous slight FDG
uptake along the border of a subpleural lung consolidation
and (2) the absence of FDG uptake within the consolidation.
Patients were referred for lung cancer initial staging (n03),
therapy response assessment (n01) and characterisation of
suspicious lung lesions (n02). Pulmonary infarction was
confirmed in all patients on contrast-enhanced MDCT and
patient follow-up (clinical examination and chest x-ray) for
at least 6 months after FDG-PET/CT. Diagnostic criteria for
pulmonary infarction was either a peripheral consolidation
with adjacent subsegmental PE on contrast-enhanced MDCT
[3] (n04) or proximal tumoral arterial obstruction in the
segment of the pulmonary infarction (n02) with exclusion
of another cause of peripheral consolidation such as obstruc-
tive pneumonia or lung tumor. Obstructive pneumonia with
central abcedation was excluded by the visualisation of nor-
mally aerated lung parenchyma between the proximal tumoral
obstruction and the subpleural consolidation. Contrast-
enhanced MDCT was either performed in the same session
as the PET/CT examination or on the following day.
All FDG-PET/CT images were obtained using 16-slice
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Netherlands) 60 min following intravenous injection of
3 MBq/kg FDG. The field of view was from the base of
the skull to mid-thigh. CT images were obtained with or
without contrast media injection using the following param-
eters: 120 KV, 100 mAs, collimation 16×1.5 mm, pitch of
0.69, slice thickness: 3 mm and increment of 1.5 mm. CT
data were used for the attenuation correction. All patients
had a serum glucose level <7.7 mmol/l at the time of
injection. On PET images, semiquantitative analysis with
measurement of the maximal standardised uptake value
(SUVmax) of the lesion exhibiting the rim sign was per-
formed. On MDCT images, morphological characteristics
associated with pulmonary infarction were recorded: trian-
gular shape, vessel sign and central lucencies [3]. Triangular
shape corresponds to a consolidation with an apex in a more
central portion of the lung than the broad base. The vessel
sign defines the presence of an enlarged vessel leading to the
apex of a consolidation. Central lucencies were defined as
round foci of hypoattenuation in the central portion of a
consolidation.
Results
Patients’ characteristics including clinical context, mecha-
nism, topography, size, SUVmax and morphologic character-
istics of pulmonary infarctions are reported in Table 1.
Eight pulmonary infarctions were diagnosed in the six
patients. Five pulmonary infarctions were related to acute
pulmonary thromboembolism (Fig. 1), and three pulmonary
infarctions were caused by hilar tumoral arterial obstruction
(Fig. 2). Median size of the pulmonary infarctions was
48.5 mm (30–74 mm). Central lucencies and triangular
shape were observed in 5/8 and 4/8 cases, respectively.
The vessel sign was present in only one lesion. Two out of
the eight pulmonary infarctions appeared as a solitary pul-
monary mass and only exhibited the rim sign, without any
of the suggestive MDCT sign (Fig. 3).
FDG uptake was considered as slight in all cases. Only
small parts of the FDG rim uptake presented a marked
intensity, with the measured SUVmax ranging between 2.2
and 6.8 (median 3.6). In all cases with PE, no FDG uptake
was observed in the arterial thrombus.
Discussion
As recently pointed out by Hofman and Hicks [6], pattern
recognition appears to be of great value in the field of PET
imaging. Hence, nuclear medicine physicians are already
used to identify some benign conditions based on the distri-
bution of FDG uptake, such as brown fat activation and
symmetric hilar node uptake. Beyond all the useful quanti-
tative parameters offered by PET technology, the next step
might be the definition of distinguishable metabolic pat-
terns. This approach has already proved its usefulness in
the response assessment of several cancers, where the
inflammatory processes associated with therapy hamper a
quantitative evaluation of tumoral uptake changes [7]. FDG
uptake intensity is useless in making the distinction among
inflammatory, infectious and tumoral lung lesions [8].
Indeed, post-stenotic atelectasis, granulomatous lung
Fig. 1 A 55-year-old man with
a metastatic right lower lobe lung
adenocarcinoma (patient 1).
FDG-PET/CT images showed a
right upper lobe subpleural
consolidation exhibiting the





confirmed the acute pulmonary
embolism (c, arrow) and showed
the vessel sign associated with
the right pulmonary infarction
(d, arrow)
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disease and many infectious lesions have demonstrated var-
ious FDG uptake patterns and can therefore mimic cancer
[9]. Regarding pulmonary infarction, there is an overlap of
the SUVmax values with lung tumors [5].
In this study we aimed to point out a distinctive pattern of
pulmonary infarction called the rim sign. This metabolic
pattern is consistent with pathologic data on pulmonary
infarction, showing that consolidation in pulmonary infarc-
tion is mainly caused by central blood alveolar filling with a
peripheral inflammatory reaction including a foamy macro-
phage margin at the edge of central necrosis [10]. FDG
uptake is certainly related to this inflammatory peripheral
process. A rim of FDG uptake in a pulmonary infarction was
described in one patient by Badr [11].
Such a metabolic pattern is however not specific for
pulmonary infarction. Hence, several consolidations such
as lung tumors with central necrosis or lung abscess can
show intense peripheral FDG uptake with low central FDG
uptake. Nevertheless, in this study, the eight pulmonary
infarctions exhibited a slight, thin and continuous FDG
uptake in all cases, with a median SUVmax value of 3.6,
which is close to those reported previously [5]. Tumors with
Fig. 2 A 53-year-old man referred for small cell lung cancer staging
(patient 2). FDG-PET/CT images showed a left upper lobe subpleural
consolidation with triangular shape and central lucencies, exhibiting
the rim sign (a, axial PET; b, axial fusion, arrows). Mediastinal tumor
with high FDG uptake is clearly visible (b, star). MDCT showed
complete arterial obstruction of the left pulmonary artery (c, arrow)
Fig. 3 A 57-year-old man referred for workup of a solitary pulmonary
mass (patient 5). FDG-PET/CT images showed a right subpleural
consolidation with the rim sign (a, axial PET; b, axial fusion, arrow).
MDCT confirmed acute pulmonary embolism (c, arrow) showing an
adjacent subsegmental pulmonary embolism. Note the absence of any
suggestive signs of pulmonary infarction on MDCT. Patient follow-up
confirmed the absence of associated lung tumor
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central necrosis or lung abscess typically appear as round
masses with stronger and thicker FDG uptake [12, 13].
The association of the rim sign with one or more of the
morphologic characteristics associated with pulmonary in-
farction may increase diagnostic confidence. Among them,
central lucencies and the vessel sign are reported as the most
specific CT findings (specificity 98 % and 89 %, respec-
tively) [3]. Unfortunately, all of these CT findings were
reported to have a very low sensitivity. Interestingly, in
two patients, the subpleural consolidation exhibited none
of the MDCT signs suggestive of pulmonary infarction. This
means that the rim sign could be the only imaging criterion
to suggest a pulmonary infarction in such cases. It is note-
worthy that in all cases of this series pulmonary infarctions
were detected incidentally. Patients did not report symptoms
suggestive of acute PE, such as acute chest pain or dyspnea.
Besides, arterial thrombi can be associated with FDG uptake
and thus help to suggest pulmonary embolism [5], but this
was not observed in our study.
Consideration of the patient’s clinical data and previous
imaging results is an additional way to avoid diagnostic
pitfalls. Thus, a parenchymal consolidation with the rim
sign appearing aside a known or under-treatment lung tumor
should raise the question of pulmonary infarction as a dif-
ferential diagnosis.
This retrospective case series study has limits. First, the
design was retrospective and the number of patients includ-
ed small. Second, this case series study did not allow an
evaluation of the sensitivity and specificity of the rim sign,
and a prospective study is needed to determine its diagnostic
accuracy.
In conclusion, the rim sign, defined as a slight and
continuous FDG uptake at the border of a peripheral lung
consolidation, is easily recognisable at FDG-PET/CT and is
strongly suggestive of pulmonary infarction. This pattern
can be observed even in the absence of any suggestive
finding of pulmonary infarction on MDCT. In daily practice,
this pattern may help the physician to refer patients for lung
perfusion scintigraphy or contrast-enhanced MDCT for pul-
monary embolism assessment.
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